Search Results - Lizza Hendriks

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer by Judith Gulikers, Jeroen Bruinsma, Janna Schoenmaekers, Safiye Dursun, Vivianne Tjan-Heijnen, Robin van Geel, Sander Croes, Lizza Hendriks

    Published in Therapeutic Advances in Medical Oncology (2024-12-01)
    Get full text
    Article


  2. 2

    Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study by Juliette Degens, D De Ruysscher, Ruud Houben, Bastiaan Kietselaer, Gerben Bootsma, Lizza Hendriks, Ellen Huijbers, Annemie Schols, Anne-Marie C Dingemans

    Published in BMJ Open (2020-09-01)
    Get full text
    Article


  3. 3

    Improving Patient Engagement in Phase 2 Clinical Trials With a Trial-Specific Patient Decision Aid: Development and Usability Study by Iva Halilaj, Relinde Lieverse, Cary Oberije, Lizza Hendriks, Charlotte Billiet, Ines Joye, Brice Van Eeckhout, Anke Wind, Anshu Ankolekar, Philippe Lambin

    Published in Journal of Medical Internet Research (2025-09-01)
    Get full text
    Article


  4. 4

    Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis by David O’Reilly, David O’Reilly, David O’Reilly, Caroline L. O’Leary, Aislinn Reilly, Min Yuen Teo, Grainne O’Kane, Lizza Hendriks, Kathleen Bennett, Jarushka Naidoo, Jarushka Naidoo, Jarushka Naidoo

    Published in Frontiers in Oncology (2024-07-01)
    Get full text
    Article


  5. 5

    Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lu... by Alessandra I. G. Buma, Berber Piet, Rob ter Heine, Michel M. van den Heuvel, Paul Brinkman, Daan van den Broek, Sjaak Burgers, Francesco Ciompi, Simona M. Cristescu, Bram van Ginneken, Katrien Grünberg, Lizza Hendriks, Jeroen Hiltermann, Firdaus Mohamed Housein, Alwin Huitema, Jakko van Inge, Colin Jacobs, Hans Koenen, Marjolijn Ligtenberg, Anke H. Maitland-van der Zee, Vincent van der Noort, Mathias Prokop, Valesca Rètel, Heinrich Roder, Huub van Rossum, Ruben Smeets, Thomas Würdinger

    Published in Frontiers in Pharmacology (2023-11-01)
    Get full text
    Article


Search Tools: